Holdings of Merck & Co., Inc.
· Original filing · Compare with another fund · Report an error
- Net assets
- -
- Positions
- 10 in 1 countries
- Top ten
- 100.0 % of the equity sleeve
- Filed on
- Mar 31, 2026
Portfolio shape
Positions
| Rank | Company | Shares | Value | Weight |
|---|---|---|---|---|
| 1 | Moderna Inc | 2,308,190 | 117.3M $ | |
| 2 | Personalis Inc | 14,044,943 | 89.5M $ | |
| 3 | Kymera Therapeutics Inc | 772,165 | 64.3M $ | |
| 4 | Eikon Therapeutics Inc | 1,666,666 | 17.6M $ | |
| 5 | Aktis Oncology Inc | 952,844 | 17M $ | |
| 6 | Alector Inc | 3,545,719 | 7.6M $ | |
| 7 | Viridian Therapeutics Inc | 93,414 | 1.8M $ | |
| 8 | Xilio Therapeutics Inc | 105,982 | 891.3K $ | |
| 9 | NEUPHORIA THERAPEUTICS INC | 10,027 | 40.8K $ | |
| 10 | TuHURA Biosciences Inc | 19,445 | 34.8K $ |
Sector breakdown
- Health care 37.1 %
- Unattributed 62.9 %
Titelia classification, company by company. The unattributed share stays visible.
Currency breakdown
- USD 100.0 %
The quoted currency of each line, as declared.
Country breakdown
- United States 100.0 %
Shares computed on the equity sleeve.
| Rank | Country | Lines | Value | Share |
|---|---|---|---|---|
| 1 | United States | 10 | 316.1M $ | 100.00 % |
Cite this page
Titelia. "Holdings of Merck & Co., Inc.". https://titelia.com/en/funds/US13F310158